日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial

稳定期多发性硬化症患者停止一线疾病修饰疗法:DOT-MS随机临床试验

Coerver, Eline M E; Fung, Wing Hee; de Beukelaar, Janet; Bouvy, Willem H; Canta, Leo R; Gerlach, Oliver H H; Hoitsma, Elske; Hoogervorst, Erwin L J; de Jong, Brigit A; Kalkers, Nynke F; van Kempen, Zoé L E; Lövenich, Harry; van Munster, Caspar E P; van Oosten, Bob W; Smolders, Joost; Vennegoor, Anke; Zeinstra, Esther M P E; Barrantes-Cepas, Mar; Kooij, Gijs; Schoonheim, Menno M; Lissenberg-Witte, Birgit I; Teunissen, Charlotte E; Moraal, Bastiaan; Barkhof, Frederik; Uitdehaag, Bernard M J; Mostert, Jop; Killestein, Joep; Strijbis, Eva M M

Association of Arachidonic Acid-Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis

花生四烯酸衍生的脂质介质与复发型和进展型多发性硬化症患者疾病严重程度的相关性

Broos, Jelle Y; Loonstra, Floor C; de Ruiter, Lodewijk R J; Gouda, Mariam; Fung, Wing Hee; Schoonheim, Menno M; Heijink, Marieke; Strijbis, Eva M M; Teunissen, Charlotte; Killestein, Joep; de Vries, Helga E; Giera, Martin; Uitdehaag, Bernard M J; Kooij, Gijs